The Liver Cancer Diagnostics Global Market Report 2023, provides comprehensive information on the liver cancer diagnostics market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Liver Cancer Diagnostics Market’s Growth:
https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report
As per The Business Research Company’s Liver Cancer Diagnostics Global Market Report 2023, the market size is expected to grow from $8.46 billion in 2022 to $9.19 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global liver cancer diagnostics market size is expected to reach $12.14 billion in 2027 at a CAGR of 7.2%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=10481&type=smp
The rising prevalence of liver cancer is expected to propel the growth of the liver cancer diagnostics market going forward. Liver cancer refers to the condition in which the liver cells grow and multiply out of control, giving rise to a life-threatening illness. Liver cancer diagnostic tests are performed to determine whether cancer cells are spreading within the liver or surrounding it after the diagnosis of primary carcinoma of the liver, so the rising prevalence of liver cancer boosts the liver cancer diagnostics market. For instance, in January 2023, according to the Cancer Facts & Figures 2023 report published by the American Cancer Society, a US-based voluntary health organization, the number of new cases of liver and intrahepatic bile duct cancer in females reached 13,230 in 2023, an increase from 12,640 in 2020, in the United States. Furthermore, in 2023, an estimated 41,210 new cases of liver cancer will be diagnosed in the US, where 29,380 people are expected to die. Therefore, the rising prevalence of liver cancer is driving the growth of the liver cancer diagnostic market.
The liver cancer diagnostics market is segmented:
1) By Type: Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma, Other Types
2) By Screening: Laboratory Testing, Imaging, Endoscopy, Biopsy, Other Screenings
3) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies
4) By End Use: Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Pharmaceutical And CRO Laboratories
North America was the largest region in the liver cancer diagnostics market in 2022.
The table of contents in TBRC’s liver cancer diagnostics market report includes:
- Executive Summary
- Liver Cancer Diagnostics Market Characteristics
- Liver Cancer Diagnostics Market Trends And Strategies
- Liver Cancer Diagnostics Market – Macro Economic Scenario
- Liver Cancer Diagnostics Market Size And Growth
.
.
.
- Middle East Liver Cancer Diagnostics Market
- Africa Liver Cancer Diagnostics Market
- Liver Cancer Diagnostics Market Competitive Landscape And Company Profiles
- Key Mergers And Acquisitions In The Liver Cancer Diagnostics Market
- Liver Cancer Diagnostics Market Future Outlook and Potential Analysis
Top Major Players
- Abbott Laboratories
- Hoffmann-La Roche Ltd.
- Qiagen N.V
- Thermo Fisher Scientific Inc.
- Siemens Healthineers
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
